Cas no 259110-61-7 (trans-3,5-difluoropiperidine;hydrochloride)
trans-3,5-difluoropiperidine;hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride
- trans-3,5-difluoropiperidine;hydrochloride
- F85935
- rel-(3R,5R)-3,5-Difluoropiperidinehydrochloride
- trans-3,5-difluoropiperidine hydrochloride
- 2940873-30-1
- (3R,5R)-3,5-DIFLUOROPIPERIDINE HYDROCHLORIDE
- CS-0187950
- (3R,5R)-3,5-difluoropiperidine;hydrochloride
- BS-16328
- (3S,5S)-3,5-DIFLUOROPIPERIDINE HYDROCHLORIDE
- AKOS037649030
- P21019
- 259110-61-7
-
- MDL: MFCD30803927
- Inchi: 1S/C5H9F2N.ClH/c6-4-1-5(7)3-8-2-4;/h4-5,8H,1-3H2;1H/t4-,5-;/m1./s1
- InChI Key: AHGKXYJWIFNPNB-TYSVMGFPSA-N
- SMILES: Cl.F[C@H]1CNC[C@@H](C1)F
Computed Properties
- Exact Mass: 157.0469833g/mol
- Monoisotopic Mass: 157.0469833g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 68.8
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 12
trans-3,5-difluoropiperidine;hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UJ841-50mg |
trans-3,5-difluoropiperidine;hydrochloride |
259110-61-7 | 95% | 50mg |
2293CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UJ841-100mg |
trans-3,5-difluoropiperidine;hydrochloride |
259110-61-7 | 95% | 100mg |
1387.0CNY | 2021-07-15 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | R57340-250mg |
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride |
259110-61-7 | 95% | 250mg |
¥3699.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | R57340-100mg |
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride |
259110-61-7 | 95% | 100mg |
¥270.0 | 2024-07-19 | |
| Chemenu | CM515789-50mg |
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride |
259110-61-7 | 95% | 50mg |
$275 | 2022-09-01 | |
| Chemenu | CM515789-100mg |
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride |
259110-61-7 | 95% | 100mg |
$347 | 2022-09-01 | |
| Chemenu | CM515789-250mg |
rel-(3R,5R)-3,5-Difluoropiperidine hydrochloride |
259110-61-7 | 95% | 250mg |
$556 | 2022-09-01 | |
| eNovation Chemicals LLC | D657326-100mg |
trans-3,5-difluoropiperidine;hydrochloride |
259110-61-7 | 97% | 100mg |
$365 | 2024-07-21 | |
| eNovation Chemicals LLC | D657326-250MG |
trans-3,5-difluoropiperidine;hydrochloride |
259110-61-7 | 97% | 250mg |
$605 | 2024-07-21 | |
| eNovation Chemicals LLC | D657326-500MG |
trans-3,5-difluoropiperidine;hydrochloride |
259110-61-7 | 97% | 500mg |
$850 | 2024-07-21 |
trans-3,5-difluoropiperidine;hydrochloride Related Literature
-
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
-
Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
-
Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
Additional information on trans-3,5-difluoropiperidine;hydrochloride
Comprehensive Guide to trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7): Properties, Applications, and Market Insights
trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7) is a fluorinated piperidine derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound belongs to the class of fluorinated heterocycles, which are known for their unique physicochemical properties and broad applications in drug discovery. The trans-configuration of the fluorine atoms at the 3 and 5 positions of the piperidine ring enhances its structural stability and bioavailability, making it a valuable intermediate in synthetic chemistry.
The growing demand for fluorinated building blocks in medicinal chemistry has positioned trans-3,5-difluoropiperidine hydrochloride as a key player in the development of novel therapeutics. Researchers are particularly interested in its potential to improve the metabolic stability and binding affinity of drug candidates. Recent studies highlight its utility in the synthesis of kinase inhibitors and G protein-coupled receptor (GPCR) modulators, addressing pressing medical needs such as oncology and central nervous system disorders.
From a chemical perspective, trans-3,5-difluoropiperidine hydrochloride exhibits remarkable solubility in polar solvents like water and methanol, which facilitates its use in various reaction conditions. Its hydrochloride salt form ensures better handling and storage stability, a critical factor for industrial-scale applications. The compound's high purity and consistent quality are essential for reproducible results in both academic and commercial research settings.
In the context of green chemistry, the synthesis of trans-3,5-difluoropiperidine hydrochloride has evolved to minimize environmental impact. Modern catalytic methods, including flow chemistry and microwave-assisted synthesis, have improved yields while reducing waste generation. These advancements align with the global push toward sustainable chemical manufacturing, a topic of high relevance in today's research landscape.
The market for fluorinated piperidines is expanding rapidly, driven by their increasing incorporation into FDA-approved drugs. Analysts project a compound annual growth rate (CAGR) of 6-8% for this segment over the next decade. trans-3,5-difluoropiperidine hydrochloride is particularly sought after by contract research organizations (CROs) and pharmaceutical companies focusing on central nervous system drugs and anti-inflammatory agents.
Quality control is paramount when working with trans-3,5-difluoropiperidine hydrochloride. Reputable suppliers provide comprehensive analytical data, including HPLC chromatograms, NMR spectra, and mass spectrometry results, to verify the compound's identity and purity. Researchers should always source this material from certified vendors to ensure compliance with Good Laboratory Practice (GLP) standards.
Looking ahead, the versatility of trans-3,5-difluoropiperidine hydrochloride suggests its continued importance in cutting-edge research. Its applications may extend to emerging fields such as proteolysis targeting chimeras (PROTACs) and covalent inhibitors, which represent revolutionary approaches in drug development. As the scientific community addresses challenges like drug resistance and targeted therapy, this compound will likely play a pivotal role in next-generation pharmaceutical innovations.
For researchers considering trans-3,5-difluoropiperidine hydrochloride for their projects, proper handling procedures should be followed despite its non-hazardous classification. Standard laboratory precautions, including the use of personal protective equipment and proper ventilation, are recommended when working with any chemical substance. The compound's Material Safety Data Sheet (MSDS) provides detailed guidance on storage conditions and handling protocols.
In conclusion, trans-3,5-difluoropiperidine hydrochloride (CAS No. 259110-61-7) stands as a testament to the importance of fluorinated heterocycles in modern chemistry. Its unique structural features, combined with growing pharmaceutical applications, make it a compound of significant interest across multiple research disciplines. As synthetic methodologies advance and new therapeutic targets emerge, this molecule will undoubtedly continue to contribute to scientific progress and innovation.
259110-61-7 (trans-3,5-difluoropiperidine;hydrochloride) Related Products
- 1228631-14-8(3,5-Difluoropiperidine)
- 737000-77-0(3-fluoropiperidine;hydrochloride)
- 871664-50-5((3S)-3-fluoropiperidine;hydrochloride)
- 1419101-53-3(cis-3,4-Difluoropiperidine hydrochloride)
- 1419101-24-8(trans-3,4-Difluoropiperidine hydrochloride)
- 116574-75-5(3-Fluoropiperidine)
- 374794-76-0(Trans-3-Fluoro-4-Methylpiperidine Hydrochloride)
- 1240528-02-2(3-Fluoroazepane)
- 1432679-15-6(3-Fluoroazepane Hydrochloride)
- 787564-37-8((3R)-3-fluoropiperidine;hydrochloride)